• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Concentra Group Holdings Parent Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    5/2/25 4:28:49 PM ET
    $CON
    Medical Specialities
    Health Care
    Get the next $CON alert in real time by email
    false 0002014596 0002014596 2025-05-01 2025-05-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    FORM 8-K

     

     

     

    CURRENT REPORT

    Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

     

    Date of Report (Date of Earliest Event Reported): May 1, 2025

     

     

     

    CONCENTRA GROUP HOLDINGS PARENT, INC.

    (Exact Name of Registrant as Specified in Its Charter)

     

     

     

    001-42188

    (Commission File Number)

     

    Delaware 30-1006613
    (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.)

     

    5080 Spectrum Drive, Suite 1200W

    Addison, TX, 75001

    (Address of principal executive offices) (Zip code)

     

    (972) 364-8000

    (Registrant’s telephone number, including area code)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class  

    Trading

    Symbol(s)

      Name of each exchange on which registered
    Common Stock, $0.01 par value per share   CON   New York Stock Exchange

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter):

     

    Emerging growth company ¨

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

     

     

     

     

     

     

    Item 5.07Submission of Matters to a Vote of Security Holders.

     

    The annual meeting of stockholders (the “Annual Meeting”) of Concentra Group Holdings Parent, Inc.’s (the “Company”) was held on May 1, 2025. At the Annual Meeting, the Company’s stockholders approved four proposals. The proposals below are described in the Company’s definitive proxy statement dated March 18, 2025. The results are as follows:

     

    Proposal 1: The Election of Two Class I Directors to the Board of Directors

     

    Name  Votes For   Votes Against   Abstentions   Broker Non-Votes 
    Daniel J. Thomas   112,356,457    5,387,232    5,412    4,847,189 
    Cheryl B. Pegus   113,994,041    3,742,087    12,973    4,847,189 

     

    Proposal 2: Non-Binding Advisory Vote on the Compensation of the Company’s Named Executive Officers

     

    Votes For   Votes Against   Abstentions   Broker Non-Votes 
    92,051,122    25,350,156    347,823    4,847,189 

     

    Proposal 3: Non-Binding Advisory Vote on the Frequency of Future Advisory Votes on the Compensation of the Company’s Named Executive Officers

     

    1 Year   2 Years   3 Years   Abstentions 
    113,659,054    19,206    4,052,275    18,566 

     

    Proposal 4: Ratification of the Appointment of PricewaterhouseCoopers LLP as the Company’s Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2025

     

    Votes For   Votes Against   Abstentions   Broker Non-Votes 
    122,300,023    291,151    5,116    0 

     

    Item 9.01 Financial Statements and Exhibits.

     

    (d) Exhibits.

     

    Exhibit
    No.
    Description
       
    104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

     

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      CONCENTRA GROUP HOLDINGS PARENT, INC.
       
    Date:  May 2, 2025 By: /s/ Timothy Ryan
        Timothy Ryan
        Executive Vice President and Chief Legal Counsel

     

     

    Get the next $CON alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CON

    DatePrice TargetRatingAnalyst
    12/16/2024$24.00Neutral → Buy
    BofA Securities
    10/7/2024$30.50 → $24.00Buy → Neutral
    BofA Securities
    8/20/2024$33.00Outperform
    RBC Capital Mkts
    8/19/2024Buy
    BofA Securities
    8/19/2024$29.00Buy
    Deutsche Bank
    8/19/2024$29.00Overweight
    JP Morgan
    8/19/2024$32.00Buy
    Goldman
    8/19/2024$28.00Outperform
    Mizuho
    More analyst ratings

    $CON
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Ortenzio Robert A disposed of 3,070,367 shares and acquired 1,023,455 shares (SEC Form 4)

      4 - Concentra Group Holdings Parent, Inc. (0002014596) (Issuer)

      3/4/25 4:59:26 PM ET
      $CON
      Medical Specialities
      Health Care
    • Officer Mcandrew Douglas R. was granted 60,000 shares (SEC Form 4)

      4 - Concentra Group Holdings Parent, Inc. (0002014596) (Issuer)

      11/29/24 5:59:48 PM ET
      $CON
      Medical Specialities
      Health Care
    • Officer Kosuth Michael A. was granted 60,000 shares (SEC Form 4)

      4 - Concentra Group Holdings Parent, Inc. (0002014596) (Issuer)

      11/29/24 5:58:45 PM ET
      $CON
      Medical Specialities
      Health Care